| A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement M Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ... Journal of hepatology 73 (1), 202-209, 2020 | 3002 | 2020 |
| Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis T Karlas, D Petroff, M Sasso, JG Fan, YQ Mi, V de Lédinghen, M Kumar, ... Journal of hepatology 66 (5), 1022-1030, 2017 | 930 | 2017 |
| Epidemiology of Helicobacter pylori Infection and Public Health Implications KL Goh, WK Chan, S Shiota, Y Yamaoka Helicobacter 16, 1-9, 2011 | 789 | 2011 |
| The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease M Eslam, SK Sarin, VWS Wong, JG Fan, T Kawaguchi, SH Ahn, ... Hepatology international 14, 889-919, 2020 | 568 | 2020 |
| FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation … PN Newsome, M Sasso, JJ Deeks, A Paredes, J Boursier, WK Chan, ... The lancet Gastroenterology & hepatology 5 (4), 362-373, 2020 | 531 | 2020 |
| Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—part 1: definition, risk factors and assessment VWS Wong, WK Chan, S Chitturi, Y Chawla, YY Dan, A Duseja, J Fan, ... Journal of gastroenterology and hepatology 33 (1), 70-85, 2018 | 475 | 2018 |
| Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis FE Mózes, JA Lee, EA Selvaraj, ANA Jayaswal, M Trauner, J Boursier, ... Gut 71 (5), 1006-1019, 2022 | 278 | 2022 |
| A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis CW Kheong, NRN Mustapha, S Mahadeva Clinical Gastroenterology and Hepatology 15 (12), 1940-1949. e8, 2017 | 214 | 2017 |
| Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease WK Chan, NR Nik Mustapha, S Mahadeva Journal of gastroenterology and hepatology 29 (7), 1470-1476, 2014 | 205 | 2014 |
| The Asia–Pacific Working Party on non‐alcoholic fatty liver disease guidelines 2017—part 2: management and special groups S Chitturi, VWS Wong, WK Chan, GLH Wong, SKH Wong, J Sollano, ... Journal of gastroenterology and hepatology 33 (1), 86-98, 2018 | 192 | 2018 |
| Appointment waiting times and education level influence the quality of bowel preparation in adult patients undergoing colonoscopy WK Chan, A Saravanan, J Manikam, KL Goh, S Mahadeva BMC gastroenterology 11, 1-9, 2011 | 181 | 2011 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 163 | 2022 |
| Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis D Petroff, V Blank, PN Newsome, CS Voican, M Thiele, V de Lédinghen, ... The Lancet Gastroenterology & Hepatology 6 (3), 185-198, 2021 | 163 | 2021 |
| Empagliflozin for the treatment of nonalcoholic steatohepatitis in patients with type 2 diabetes mellitus LL Lai, SR Vethakkan, NR Nik Mustapha, S Mahadeva, WK Chan Digestive diseases and sciences 65, 623-631, 2020 | 156 | 2020 |
| Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement GLH Wong, VWS Wong, A Thompson, J Jia, J Hou, CRA Lesmana, ... The Lancet Gastroenterology & Hepatology 5 (8), 776-787, 2020 | 153 | 2020 |
| Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease VWS Wong, M Irles, GLH Wong, S Shili, AWH Chan, W Merrouche, ... Gut 68 (11), 2057-2064, 2019 | 134 | 2019 |
| Screening for non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography LL Lai, WNI Wan Yusoff, SR Vethakkan, NR Nik Mustapha, S Mahadeva, ... Journal of gastroenterology and hepatology 34 (8), 1396-1403, 2019 | 106 | 2019 |
| Non‐alcoholic fatty liver disease in diabetics–prevalence and predictive factors in a multiracial hospital clinic population in M alaysia WK Chan, ATB Tan, SR Vethakkan, PC Tah, A Vijayananthan, KL Goh Journal of gastroenterology and hepatology 28 (8), 1375-1383, 2013 | 95 | 2013 |
| Optimizing use of nonalcoholic fatty liver disease fibrosis score, fibrosis-4 score, and liver stiffness measurement to identify patients with advanced fibrosis WK Chan, S Treeprasertsuk, GBB Goh, JG Fan, MJ Song, ... Clinical Gastroenterology and Hepatology 17 (12), 2570-2580. e37, 2019 | 88 | 2019 |
| Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population WK Chan, NR Nik Mustapha, GLH Wong, VWS Wong, S Mahadeva United European gastroenterology journal 5 (1), 76-85, 2017 | 86 | 2017 |
Sanjiv MahadevaDepartment of Medicine, Faculty of Medicine, University of MalayaVerified email at ummc.edu.my
